1-240092805-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020066.5(FMN2):​c.696T>C​(p.Pro232Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00457 in 1,585,654 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0046 ( 23 hom. )

Consequence

FMN2
NM_020066.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.00300

Publications

1 publications found
Variant links:
Genes affected
FMN2 (HGNC:14074): (formin 2) This gene is a member of the formin homology protein family. The encoded protein is thought to have essential roles in organization of the actin cytoskeleton and in cell polarity. This protein mediates the formation of an actin mesh that positions the spindle during oogenesis and also regulates the formation of actin filaments in the nucleus. This protein also forms a perinuclear actin/focal-adhesion system that regulates the shape and position of the nucleus during cell migration. Mutations in this gene have been associated with infertility and also with an autosomal recessive form of intellectual disability (MRT47). Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jul 2017]
FMN2 Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal recessive 47
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-240092805-T-C is Benign according to our data. Variant chr1-240092805-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 435216.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.003 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00387 (589/152240) while in subpopulation NFE AF = 0.00594 (404/67998). AF 95% confidence interval is 0.00546. There are 1 homozygotes in GnomAd4. There are 278 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 23 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FMN2NM_020066.5 linkc.696T>C p.Pro232Pro synonymous_variant Exon 1 of 18 ENST00000319653.14 NP_064450.3 Q9NZ56-1Q9HBL1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FMN2ENST00000319653.14 linkc.696T>C p.Pro232Pro synonymous_variant Exon 1 of 18 5 NM_020066.5 ENSP00000318884.9 Q9NZ56-1
FMN2ENST00000447095.5 linkc.-87+24732T>C intron_variant Intron 2 of 6 3 ENSP00000409308.1 B0QZA8

Frequencies

GnomAD3 genomes
AF:
0.00387
AC:
589
AN:
152122
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.00392
Gnomad ASJ
AF:
0.00518
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00395
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00594
Gnomad OTH
AF:
0.00575
GnomAD2 exomes
AF:
0.00378
AC:
728
AN:
192700
AF XY:
0.00381
show subpopulations
Gnomad AFR exome
AF:
0.000943
Gnomad AMR exome
AF:
0.00430
Gnomad ASJ exome
AF:
0.00729
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00395
Gnomad NFE exome
AF:
0.00542
Gnomad OTH exome
AF:
0.00435
GnomAD4 exome
AF:
0.00465
AC:
6661
AN:
1433414
Hom.:
23
Cov.:
89
AF XY:
0.00451
AC XY:
3205
AN XY:
710578
show subpopulations
African (AFR)
AF:
0.000849
AC:
28
AN:
32980
American (AMR)
AF:
0.00427
AC:
170
AN:
39816
Ashkenazi Jewish (ASJ)
AF:
0.00709
AC:
181
AN:
25514
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38424
South Asian (SAS)
AF:
0.000132
AC:
11
AN:
83614
European-Finnish (FIN)
AF:
0.00394
AC:
197
AN:
49974
Middle Eastern (MID)
AF:
0.000391
AC:
2
AN:
5110
European-Non Finnish (NFE)
AF:
0.00528
AC:
5801
AN:
1098694
Other (OTH)
AF:
0.00457
AC:
271
AN:
59288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
529
1057
1586
2114
2643
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00387
AC:
589
AN:
152240
Hom.:
1
Cov.:
33
AF XY:
0.00373
AC XY:
278
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41554
American (AMR)
AF:
0.00392
AC:
60
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00518
AC:
18
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5140
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00395
AC:
42
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00594
AC:
404
AN:
67998
Other (OTH)
AF:
0.00569
AC:
12
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
30
60
89
119
149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00499
Hom.:
1
Bravo
AF:
0.00365
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FMN2: BP4, BP7, BS2 -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 17, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FMN2-related disorder Benign:1
Jun 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
8.0
DANN
Benign
0.67
PhyloP100
-0.0030
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11583501; hg19: chr1-240256105; API